WO2005042031A3 - Oligoribonukleotide zur behandlung von unerwünschter pigmentierung der haut und der haare durch rna-interferenz - Google Patents

Oligoribonukleotide zur behandlung von unerwünschter pigmentierung der haut und der haare durch rna-interferenz Download PDF

Info

Publication number
WO2005042031A3
WO2005042031A3 PCT/EP2004/012422 EP2004012422W WO2005042031A3 WO 2005042031 A3 WO2005042031 A3 WO 2005042031A3 EP 2004012422 W EP2004012422 W EP 2004012422W WO 2005042031 A3 WO2005042031 A3 WO 2005042031A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligoribonucleotides
treatment
rna interference
hair pigmentation
pigmentation due
Prior art date
Application number
PCT/EP2004/012422
Other languages
English (en)
French (fr)
Other versions
WO2005042031A2 (de
Inventor
Rainer Wolber
Christoph Smuda
Thomas Blatt
Claudia Mundt
Werner Berens
Stefan Gallinat
Original Assignee
Beiersdorf Ag
Rainer Wolber
Christoph Smuda
Thomas Blatt
Claudia Mundt
Werner Berens
Stefan Gallinat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag, Rainer Wolber, Christoph Smuda, Thomas Blatt, Claudia Mundt, Werner Berens, Stefan Gallinat filed Critical Beiersdorf Ag
Priority to EP04797559A priority Critical patent/EP1682187A2/de
Publication of WO2005042031A2 publication Critical patent/WO2005042031A2/de
Publication of WO2005042031A3 publication Critical patent/WO2005042031A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Doppelsträngiges Oligoribonukleotid oder ein physiologisch verträgliches Salz davon, das in der Lage ist, den Abbau von mRNA von einem oder mehreren an der Pigmentierung der Haut und/oder der Haare beteiligten Strukturen zu induzieren.
PCT/EP2004/012422 2003-11-03 2004-11-03 Oligoribonukleotide zur behandlung von unerwünschter pigmentierung der haut und der haare durch rna-interferenz WO2005042031A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04797559A EP1682187A2 (de) 2003-11-03 2004-11-03 Oligoribonukleotide zur behandlung von unerw nschter pigment ierung der haut und der haare durch rna-interferenz

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2003151149 DE10351149A1 (de) 2003-11-03 2003-11-03 Oligoribonukleotide zur Behandlung von unerwünschter Pigmentierung der Haut und der Haare durch RNA-Interferenz
DE10351149.0 2003-11-03

Publications (2)

Publication Number Publication Date
WO2005042031A2 WO2005042031A2 (de) 2005-05-12
WO2005042031A3 true WO2005042031A3 (de) 2005-09-09

Family

ID=34530030

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/012422 WO2005042031A2 (de) 2003-11-03 2004-11-03 Oligoribonukleotide zur behandlung von unerwünschter pigmentierung der haut und der haare durch rna-interferenz

Country Status (3)

Country Link
EP (1) EP1682187A2 (de)
DE (1) DE10351149A1 (de)
WO (1) WO2005042031A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2890859B1 (fr) * 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007924A1 (en) * 1993-09-17 1995-03-23 Andy Shih Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
WO1997014709A1 (en) * 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Antisense oligomers
WO2001058918A2 (fr) * 2000-02-11 2001-08-16 Lvmh Recherche Oligonucleotides modulant l'expression d'enzymes intervenant dansla synthese de pigments melaniques
WO2001070949A1 (en) * 2000-03-17 2001-09-27 Benitec Australia Ltd Genetic silencing
WO2001075164A2 (en) * 2000-03-30 2001-10-11 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference
WO2003042385A2 (en) * 2001-11-12 2003-05-22 Epiclone, Inc. Gene silencing using sense dna and antisense rna hybrid constructs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19750702A1 (de) * 1997-11-15 1999-05-27 Hoechst Marion Roussel De Gmbh Antisense Oligonucleotide gegen Tenascin zur Behandlung von Vitiligo
US20030084471A1 (en) * 2000-03-16 2003-05-01 David Beach Methods and compositions for RNA interference

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007924A1 (en) * 1993-09-17 1995-03-23 Andy Shih Ribozyme-based compositions for the modification of cutaneous phenotypes associated with aging and other conditions of the skin and hair
WO1997014709A1 (en) * 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Antisense oligomers
WO2001058918A2 (fr) * 2000-02-11 2001-08-16 Lvmh Recherche Oligonucleotides modulant l'expression d'enzymes intervenant dansla synthese de pigments melaniques
WO2001070949A1 (en) * 2000-03-17 2001-09-27 Benitec Australia Ltd Genetic silencing
WO2001075164A2 (en) * 2000-03-30 2001-10-11 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference
WO2003042385A2 (en) * 2001-11-12 2003-05-22 Epiclone, Inc. Gene silencing using sense dna and antisense rna hybrid constructs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BOONANUNTANASARN S ET AL: "Specific gene silencing using small interfering RNAs in fish embryos", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 310, no. 4, 31 October 2003 (2003-10-31), pages 1089 - 1095, XP004464075, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO2005042031A2 (de) 2005-05-12
DE10351149A1 (de) 2005-06-30
EP1682187A2 (de) 2006-07-26

Similar Documents

Publication Publication Date Title
GB0025639D0 (en) Cosmetic treatment of skin conditions
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
AU2001279707A1 (en) Diagnosis of behavioural disorders, neurological disorders and cancer
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
GB0520687D0 (en) Skin treatment formulations
AUPQ877300A0 (en) Topical treatment of skin
WO2005020877A3 (de) Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken
MXPA03003836A (es) Tratamiento de espuma de productos de tisu.
EP1636160A4 (de) Neue therapeutische mittel zur behandlung von krebs, stoffwechselkrankheiten und hauterkrankungen
HK1176817A1 (zh) 奧蘭西丁水溶液及其製備方法和消毒劑
IL166016A0 (en) Topical treatment of skin diseases
PT2119472E (pt) Sistema de tratamento de pele/cabelo
PT1979053E (pt) Produto para tratar a pele e as membranas mucosas, e método relativo à sua preparação
AU2002366530A1 (en) Utilization of dihydropinosylvin and derivatives thereof as tyrosinase inhibitors for skin lightening or as antimicrobial substances for preservation or for the treatment of acne, dandruff or body odors
WO2005042031A3 (de) Oligoribonukleotide zur behandlung von unerwünschter pigmentierung der haut und der haare durch rna-interferenz
GB2360453B (en) Treatment of skin conditions
MXPA03004449A (es) Metodo cosmetico para tratar la piel.
WO2003044167A3 (en) Antisense modulation of human fxr expression
GB0101146D0 (en) Treatment of skin conditions
WO2002040637A3 (en) Antisense modulation of pi3k p85 expression
AU2003237742A1 (en) Composition for the treatment of skin diseases and for improving hair growth
AU2002241416A1 (en) Dermatological agent for the treatment of skin trauma, especially in burn conditions
AU2002357815A1 (en) Neutralization of stratum corneum to treat hyperkeratotic skin lesions
AU2003273247A1 (en) Non-invasive methods to identify agents for treating pain
AU2003297570A1 (en) Treatment of skin diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004797559

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004797559

Country of ref document: EP